ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 163 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $209,784 | -7.3% | 66,178 | +45.4% | 0.00% | -20.0% |
Q2 2023 | $226,284 | +6.5% | 45,530 | +5.9% | 0.01% | 0.0% |
Q1 2023 | $212,420 | +53.5% | 43,000 | +95.5% | 0.01% | +25.0% |
Q4 2022 | $138,380 | -70.2% | 22,000 | -48.8% | 0.00% | -69.2% |
Q3 2022 | $464,000 | -5.3% | 43,000 | 0.0% | 0.01% | -13.3% |
Q2 2022 | $490,000 | +25.0% | 43,000 | 0.0% | 0.02% | +66.7% |
Q1 2022 | $392,000 | -38.9% | 43,000 | 0.0% | 0.01% | -40.0% |
Q4 2021 | $642,000 | -42.0% | 43,000 | -0.1% | 0.02% | -48.3% |
Q3 2021 | $1,106,000 | -1.3% | 43,047 | +0.1% | 0.03% | -12.1% |
Q2 2021 | $1,121,000 | -26.2% | 43,000 | 0.0% | 0.03% | -47.6% |
Q1 2021 | $1,518,000 | +39.9% | 43,000 | 0.0% | 0.06% | +31.2% |
Q4 2020 | $1,085,000 | -33.1% | 43,000 | 0.0% | 0.05% | -44.8% |
Q3 2020 | $1,622,000 | -11.9% | 43,000 | 0.0% | 0.09% | -26.9% |
Q2 2020 | $1,841,000 | +120.2% | 43,000 | 0.0% | 0.12% | +77.6% |
Q1 2020 | $836,000 | -25.2% | 43,000 | 0.0% | 0.07% | -31.6% |
Q4 2019 | $1,117,000 | – | 43,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $45,386,000 | 9.32% |
TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $472,400,000 | 5.23% |
Wildcat Capital Management, LLC | 1,515,524 | $38,252,000 | 4.81% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 900,143 | $22,720,000 | 3.28% |
Coastal Bridge Advisors, LLC | 385,824 | $9,738,000 | 1.93% |
Casdin Capital, LLC | 945,000 | $23,852,000 | 0.71% |
DSAM Partners (London) Ltd | 208,798 | $5,270,000 | 0.62% |
BAINCO INTERNATIONAL INVESTORS | 152,839 | $3,858,000 | 0.44% |
Pier Capital, LLC | 152,071 | $3,838,000 | 0.41% |
Woodline Partners LP | 567,539 | $14,325,000 | 0.38% |